← Leaderboards
Jacques J. Kessl
Ohio State University
$6,634,291
Attributed
$6,634,291
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,634,291 · 5
By mechanism
P20$3,583,071 · 1
R01$1,802,178 · 1
R21$1,249,042 · 3
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Sung Ok Yoon$8,885,626
- Kristine E Yoder$6,387,948
- James Robert Fuchs$4,283,906
- Anthony P Young$3,695,897
- John Douglas Walters$1,566,695
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeHiv-1Integrase InhibitorsViral DnaResistanceReportingViralIntegraseIn VitroAffectEnzymesDesignBaseFutureAntiviral AgentsCellsMorphologyMutantBinding SitesInfectionGenomeComplexInhibitor/AntagonistMaps
Grant awards (14)
Developmental Research Project Core$1,212,501
P20 · FY2025 · GM · contact PI
New Inhibitors Targeting HIV-1 Integrase During Viral Maturation$367,797
R01 · FY2025 · AI · contact PI
Developmental Research Project Core$1,257,955
P20 · FY2024 · GM · contact PI
Developmental Research Project Core$1,112,615
P20 · FY2023 · GM · contact PI
New Inhibitors Targeting HIV-1 Integrase During Viral Maturation$355,349
R01 · FY2022 · AI · contact PI
New Inhibitors Targeting HIV-1 Integrase During Viral Maturation$355,517
R01 · FY2021 · AI · contact PI
New Inhibitors Targeting HIV-1 Integrase During Viral Maturation$355,680
R01 · FY2020 · AI · contact PI
New Inhibitors Targeting HIV-1 Integrase During Viral Maturation$367,835
R01 · FY2019 · AI · contact PI
Mode of Action of Allosteric HIV-1 Integrase Inhibitors during Late Steps of Viral Replication$222,000
R21 · FY2017 · AI · contact PI
Mode of Action of Allosteric HIV-1 Integrase Inhibitors during Late Steps of Viral Replication$184,427
R21 · FY2016 · AI · contact PI
Role of HIV-1 Integrase in the Late Stage of Viral Replication$231,000
R21 · FY2015 · AI · contact PI
Role of HIV-1 Integrase in the Late Stage of Viral Replication$192,240
R21 · FY2014 · AI · contact PI
Inhibitors Targeting HIV Integrase Multimers$228,750
R21 · FY2012 · AI · contact PI
Inhibitors Targeting HIV Integrase Multimers$190,625
R21 · FY2011 · AI · contact PI